NCT02730572 - Concerta (Methylphenidate) -To-Generic Switch Study | Biotech Hunter

Enrollment

1,464

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

Attention Deficit Disorder With Hyperactivity

Interventions

DRUG

Concerta

This is an observational study. Participants who have been on Concerta for at least 60 days will be observed.

DRUG

Concerta AG formulation

This is an observational study. Participants who have been on Concerta for at least 60 days and switch to authorized generic will be observed.

DRUG

Concerta EG formulation

This is an observational study. Participants who have been on Concerta for at least 60 days and switch to equivalent generic will be observed.

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY